John Hopkins experts advise greater caution for COPD sufferersLung disease experts at Johns Hopkins have advocated for greater caution in prescribing inhaled corticosteroids for COPD (chronic obstructive pulmonary disease) sufferers.

This call for caution came after evidence suggested that inhaled corticosteroids, one of the most widely used anti-inflammatory medications, increase the risk of pneumonia by a full third.

This study is expected to provide a great relief to existing 120,000 Americans suffering from COPD, which is expected to become the nation’s third leading cause of death in the United States by the year 2020.